Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Total Current Liabilities (2020 - 2023)

Historic Total Current Liabilities for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $23.4 million.

  • Cullinan Therapeutics' Total Current Liabilities fell 1354.5% to $23.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $23.4 million, marking a year-over-year decrease of 1354.5%. This contributed to the annual value of $22.5 million for FY2022, which is 9153.75% up from last year.
  • According to the latest figures from Q3 2023, Cullinan Therapeutics' Total Current Liabilities is $23.4 million, which was down 1354.5% from $19.7 million recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Total Current Liabilities high stood at $62.0 million for Q2 2022, and its period low was $5.7 million during Q2 2021.
  • Over the past 4 years, Cullinan Therapeutics' median Total Current Liabilities value was $18.5 million (recorded in 2022), while the average stood at $20.6 million.
  • Per our database at Business Quant, Cullinan Therapeutics' Total Current Liabilities surged by 98018.46% in 2022 and then plummeted by 6828.24% in 2023.
  • Over the past 4 years, Cullinan Therapeutics' Total Current Liabilities (Quarter) stood at $14.3 million in 2020, then dropped by 17.97% to $11.7 million in 2021, then surged by 91.54% to $22.5 million in 2022, then grew by 4.2% to $23.4 million in 2023.
  • Its Total Current Liabilities stands at $23.4 million for Q3 2023, versus $19.7 million for Q2 2023 and $26.2 million for Q1 2023.